3,4-dihydroxyacetophenone has been researched along with Fetal Growth Retardation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, BJ; Huang, YP; Li, Y; Ma, TY; Shan, ZZ; Si, YZ; Sun, YP; Wen, LZ; Wu, XR; Yang, DS | 1 |
| Huang, YP; Ma, TY | 1 |
2 other study(ies) available for 3,4-dihydroxyacetophenone and Fetal Growth Retardation
| Article | Year |
|---|---|
The utero-placental circulation, eugenics and the prevention and treatment of high risk pregnancies.
Topics: Acetophenones; Drugs, Chinese Herbal; Epoprostenol; Female; Fetal Growth Retardation; Humans; Placental Circulation; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy, High-Risk; Thromboxane A2 | 1994 |
[Effect of 3,4-dihydroxyacetophenone treatment on intrauterine growth retardation].
Topics: 6-Ketoprostaglandin F1 alpha; Acetophenones; Female; Fetal Growth Retardation; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Pregnancy; Thromboxane B2 | 1993 |